Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma

SIMPLE SUMMARY: For patients with metastatic melanoma, a rapid BRAF mutation assessment is vital to reveal the treatment options per patient. Additionally, close monitoring of the disease during treatment is essential to allow for adjustments in the treatment strategy when needed. The aim of this pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolmeijer, Sofie H., Koornstra, Rutger H. T., de Groot, Jan Willem B., Geerlings, Maartje J., van Rens, Dirk H., Boers-Sonderen, Marye J., Schalken, Jack A., Gerritsen, Winald R., Ligtenberg, Marjolijn J. L., Mehra, Niven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345527/
https://www.ncbi.nlm.nih.gov/pubmed/34359813
http://dx.doi.org/10.3390/cancers13153913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345527/
https://www.ncbi.nlm.nih.gov/pubmed/34359813
http://dx.doi.org/10.3390/cancers13153913

Ejemplares similares